rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2003-3-31
|
pubmed:abstractText |
To generate a candidate HPV16 vaccine for experimental and therapeutical use for cervical cancer.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1003-9279
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12665900-Animals,
pubmed-meshheading:12665900-Female,
pubmed-meshheading:12665900-Genes, Viral,
pubmed-meshheading:12665900-Genetic Vectors,
pubmed-meshheading:12665900-Mice,
pubmed-meshheading:12665900-Mice, Inbred C57BL,
pubmed-meshheading:12665900-Mutation,
pubmed-meshheading:12665900-Neoplasms, Experimental,
pubmed-meshheading:12665900-Oncogene Proteins, Viral,
pubmed-meshheading:12665900-Papillomaviridae,
pubmed-meshheading:12665900-Papillomavirus E7 Proteins,
pubmed-meshheading:12665900-Recombination, Genetic,
pubmed-meshheading:12665900-Repressor Proteins,
pubmed-meshheading:12665900-Transfection,
pubmed-meshheading:12665900-Vaccinia virus
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response].
|
pubmed:affiliation |
Institute of Virology, Chinese Academy of Preventive Medicine, Beijing 100052, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|